Validated and Characterized Antibodies
NCI makes validated antibodies and SOPs for biomarker assays available to investigators for their cancer research.
Antibody Characterization Program
NCI's Antibody Characterization Program comprehensively characterizes monoclonal antibodies or other renewable affinity reagents for use in cancer-related research via its Antibody Characterization Laboratory located at the Frederick National Laboratory for Cancer Research.
Clinical Pharmacodynamic Biomarker Assays
The DCTD Clinical Pharmacodynamic Program has developed pharmacodynamic biomarker assays intended to investigate drug and downstream drug-induced effects.